Clinical Trials on Hookworm Infections

Total 56358 results

ModernaTX, Inc.

Active, not recruiting

A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1468 in Healthy Adults ≥50 Years of Age

Herpes Zoster

United States, Puerto Rico
GlaxoSmithKline

Completed

Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A When Co-administered With Prevenar13 in Adults Aged 50 Years and Older

Herpes Zoster

United States, Germany, Estonia, Canada
Maruho Co., Ltd.

Completed

Phase III Study of ASP2151 in Herpes Zoster Patients

Herpes Zoster

Japan
GlaxoSmithKline

Completed

Safety and Immunogenicity Study of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine GSK1437173A When Administered Subcutaneously Intramuscularly in Adults Aged ≥50 Years

Herpes Zoster

Japan
GlaxoSmithKline

Completed

Safety and Immunogenicity of Different Dosing Schedules of GlaxoSmithkline (GSK) Biologicals' Herpes Zoster (HZ) Vaccine in Adults 50 Years of Age or Older

Herpes Zoster

United States, Estonia
GlaxoSmithKline

Completed

Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine in Adults 18 Years of Age or Older With Renal Transplant

Herpes Zoster

Spain, Taiwan, Italy, Canada, Belgium, Finland, Korea, Republic of, Panama, Czechia
GlaxoSmithKline

Completed

Safety and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine 1437173A in Healthy Ethnic Japanese Adults

Herpes Zoster

Australia
GlaxoSmithKline

Completed

Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A

Herpes Zoster

United States, Australia, France, Spain, Finland, Estonia, Russian Federation, Taiwan, Belgium, Korea, Republic of, Czechia, Germany, Hong Kong, Israel, Turkey, United Kingdom, Greece, Romania, Netherlands, Italy, South Africa, Ca... and more
GlaxoSmithKline

Completed

Safety & Immunogenicity of GlaxoSmithKline Biologicals' Herpes Zoster Vaccine 1437173A

Herpes Zoster

United States
Yung Shin Pharm. Ind. Co., Ltd.

Completed

A Study of Vacyless® Versus Valtrex® in Patients With Herpes Zoster (Vacyless®)

Herpes Zoster

Taiwan
Federal State Budgetary Organization, Federal Center...

Completed

Microbiological Structure of Pathogens of Periprosthetic Infection of Large Joints in the Post-Covid Period

Joint Infection | Periprosthetic Left Knee Joint Infection

Russian Federation
Qilu Hospital of Shandong University

Not yet recruiting

Efficacy and Safety of Bismuth Quadruple Therapy Containing Cefuroxime and Tetracycline as First-line Therapy for Eradicating Helicobacter Pylori in Patients Allergic to Penicillin

Helicobacter Pylori Infection

China
University Medical Centre Ljubljana

Recruiting

Bismuth Quadruple Therapy Versus Standard Triple Therapy (BismoHelP)

Helicobacter Pylori Infection

Slovenia
Chinese University of Hong Kong

Active, not recruiting

FMT for Moderate to Severe CDI: A Randomised Study With Concurrent Stool Microbiota Assessment

Clostridium Difficile Infection

Hong Kong
Shanghai East Hospital

Suspended

Bismuth Quadruple Therapy With Cefuroxime for Helicobacter Pylori Eradication Treatment

Helicobacter Pylori Infection

China
Boston Medical Center

Terminated

Fecal Microbiota Transplant for Primary CDI

Clostridium Difficile Infection

United States
Professor Mark Wilcox
The Leeds Teaching Hospitals NHS Trust; Astellas Pharma Europe Ltd.; St George...

Completed

Does Fidaxomicin Therapy Reduce Spread of Clostridium Difficile?

Clostridium Difficile Infection

United Kingdom
McMaster University
St. Joseph's Healthcare Hamilton; Hamilton Health Sciences Corporation; Queen... and other collaborators

Completed

Multi-Centre Trial of Fresh vs. Frozen-and-Thawed FMT for Recurrent CDI

Clostridium Difficile Infection

Canada
Heinrich-Heine University, Duesseldorf
German Research Foundation

Completed

Staphylococcus Aureus Bacteremia Antibiotic Treatment Options (SABATO)

Staphylococcus Aureus Infection

France, Germany, Netherlands, Spain, United Kingdom
Shandong University

Unknown

Efficacy and Safety of 14-day Concomitant Therapy for Helicobacter Pylori Infection

Helicobacter Pylori Infection

China
Chonbuk National University Hospital

Completed

Efficacy and Safety of InSan Bamboo Salt on Improvement of Helicobacter Pylori Infection

Helicobacter Pylori Infection

Korea, Republic of
Mackay Memorial Hospital

Completed

Intraluminal Clarithromycin Powder Monotherapy for Helicobacter Pylori Infection

Helicobacter Pylori Infection

Taiwan
Mackay Memorial Hospital

Completed

Intraluminal Metronidazole Powder Monotherapy for Helicobacter Pylori Infection

Helicobacter Pylori Infection

Taiwan
National Taiwan University Hospital

Unknown

Sequential Versus Quadruple Therapy in the Second-line Treatment

Helicobacter Pylori Infection

Taiwan
Bulent Ecevit University

Completed

The Effects of a Synbiotic Addition on Eradication Therapy of Helicobacter Pylori Infection in Children

Helicobacter Pylori Infection
Yonsei University

Completed

Descriptive Epidemiology of Clostridium Difficile Infection in Hospitalized Adult Patients in the Asia Pacific Region

Clostridium Difficile Infection

Korea, Republic of
Denver Health and Hospital Authority
United States Department of Defense; Accelerate Diagnostics, Inc.

Completed

Study of Accuracy of New Diagnostic Technology to Guide Rapid Antibiotic Treatment for Serious Infections

Skin and Subcutaneous Tissue Bacterial Infections | Healthcare-associated Infection | INFECTIONS | Infection Due to Resistant Bacteria

United States
Hospital Universitario Evangelico de Curitiba

Not yet recruiting

Treatment of CDI and Recurrence With Fecal Microbiota Transplant Using Promicrobioma

Clostridium Difficile Infections
Shanghai Pulmonary Hospital, Shanghai, China

Recruiting

Rapid and Accurate Detection of Major Mycobacterium Species in Pulmonary Infection Based on GenSeizer Platform

Mycobacterium Pulmonary Infection

China
Basilea Pharmaceutica

Completed

Ceftobiprole in the Treatment of Resistant Staphylococcus Aureus Skin and Skin Structure Infections

Skin Diseases, Infectious | Staphylococcal Skin Infections | Skin Diseases, Bacterial
Basilea Pharmaceutica

Completed

Ceftobiprole in the Treatment of Resistant Staphylococcus Aureus Skin and Skin Structure Infections

Skin Diseases, Infectious | Staphylococcal Skin Infections | Skin Diseases, Bacterial
University of Colorado, Denver
University of Rochester

Enrolling by invitation

Serum Based Diagnosis of and Monitoring of Infection Recovery in Orthopedic Spine Implant Infections

Surgical Site Infection | Staphylococcus Aureus Infection | Orthopedic Procedures | Spine

United States
Shenzhen Shenxin Biotechnology Co., Ltd

Not yet recruiting

A Study to Describe the Safety, Reactogenicity, and Immunogenicity of Herpes Zoster IN001 mRNA Vaccine (IN001) in Healthy Participants

Herpes Zoster
Lee's Pharmaceutical Limited

Not yet recruiting

Non-inferiority Study of ZK-A03 in Treatment of Herpes Zoster Before and After the Alteration of the Active Ingredient Manufacturer

Herpes Zoster
Wuhan BravoVax Co., Ltd.
Shanghai BravoBio Co., Ltd.

Not yet recruiting

Phase I Clinical Trial of a Candidate Herpes Zoster Vaccine

Herpes Zoster
MAXVAX Biotechnology Limited Liability Company
Henan Center for Disease Control and Prevention

Active, not recruiting

Safety and Immunogenicity of Recombinant Herpes Zoster Vaccine (CHO Cells) in Healthy Subjects Aged 18 Years and Above

Herpes Zoster

China
GlaxoSmithKline

Completed

A Long-term Follow-up Study (ZOE-LTFU) of Two Studies 110390 (ZOSTER-006) and 113077 (ZOSTER-022) to Assess the Efficacy, Safety, and Immunogenicity Persistence of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine and Assessment of 1 or 2 Additional Doses in Two Subgroups of Older Adults

Herpes Zoster

United States, Australia, Spain, Finland, Germany, Japan, Taiwan, Sweden, Korea, Republic of, Brazil, Mexico, Canada, Italy, France, Czechia, Estonia, Hong Kong, United Kingdom
GlaxoSmithKline

Active, not recruiting

A Study on the Long-term Efficacy, Safety and Persistence of Immune Response of a Vaccine Against Herpes Zoster in Older Adults

Herpes Zoster

United States, Australia, Finland, Germany, Japan, Taiwan, Sweden, Spain, Korea, Republic of, Brazil, Mexico, Italy, Canada, Czechia, Estonia, France, Hong Kong, United Kingdom
GlaxoSmithKline

Active, not recruiting

A Study to Test GlaxoSmithKline's (GSK) Herpes Zoster (HZ) Subunit Vaccine's Long-term Immune Response in Previously Vaccinated Kidney Transplant Adults and Then to Test if 2 Additional Doses of the Vaccine Are Safe and Able to Generate an Immune Response

Herpes Zoster

Spain, Canada, Belgium, Finland, Korea, Republic of, Panama, Taiwan
GlaxoSmithKline

Completed

Study to Evaluate Efficacy, Safety and Immunogenicity of GSK Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A in Adults Aged 50 Years and Older

Herpes Zoster

United States, Australia, Spain, Finland, Germany, Japan, Taiwan, Canada, Sweden, Korea, Republic of, Czechia, Hong Kong, Mexico, Italy, Brazil, Estonia, France, United Kingdom
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Participants Undergoing Hematopoietic Cell Transplants (HCTs) (V212-001)

Herpes Zoster
EMS

Completed

Efficacy of Oral Famciclovir Versus Aciclovir Treatment in Patients With Herpes Zoster

Herpes Zoster

Brazil
University of Sydney

Completed

Herpes Zoster Vaccine for Bone Marrow Transplant Donors (VZV-Zostavax)

Herpes Zoster

Australia
GlaxoSmithKline

Completed

Study of Long Term Immune Responses and Safety of the GSK Herpes Zoster Vaccine in Healthy Subjects

Herpes Zoster

Germany, Czechia, Sweden, Netherlands
Miguel Armando Mosquera Gordillo, MD
Complejo Hospitalario de Navarra

Completed

Fusarium Keratitits in Spain 2012 to 2014

Corneal Ulcer | Fusarium Infection
Christian Hvas
Innovation Fund Denmark

Active, not recruiting

Fecal Microbiota Transplantation for Early Clostridioides Difficile Infection (EarlyFMT)

Clostridium Difficile Infection | Clostridioides Difficile Infection

Denmark
Hanyang University Seoul Hospital
Pfizer; Korean Center for Disease Control and Prevention

Unknown

Clostridioides Difficile Infection - a Prospective Nationwide Epidemiologic Study in Korea

Clostridium Difficile Infection
St. Anna Kinderkrebsforschung

Withdrawn

Virus-specific ImmunoTherapy Following Allogeneic Stem Cell Transplantation (VISIT)

Cytomegalovirus Infection | Adenovirus Infection

Austria
Merck Sharp & Dohme LLC

Completed

Safety, Efficacy, and Pharmacokinetics (PK) of Daptomycin (MK-3009) in Japanese Pediatric Subjects With Complicated Skin and Soft Tissue Infections (cSSTI) and Bacteremia (MK-3009-029)

Skin Diseases, Infectious | Bacteremia | Soft Tissue Infections

Japan
Universidad Autonoma de Nuevo Leon

Completed

Spinal Infection Management With Structural Allograft

Syndrome | Bone Diseases, Infectious | Allografts | Disease of Bone | Spine Infection | Bone Graft; Complications, Fracture

Mexico

Clinical Trials on Hookworm Infections

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Japan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations